Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–11 of 11 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT05281471
- Conditions
- Adnexal Diseases, DNA Virus Infections, Endocrine Gland Neoplasms, +26 more
- Locations
-
- The University of South Alabama, Mitchell Cancer Institute Mobile, Alabama, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
- City of Hope Duarte, California, United States
- UC San Diego Health - Moores Cancer Center La Jolla, California, United States
Recruiting
Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100
NCT06065462
- Conditions
- Ovarian Clear Cell Carcinoma
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Recruiting
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma
NCT07002346
- Conditions
- Ovarian Clear Cell Carcinoma
- Locations
-
- Tongji Hospital Wuhan, Hubei, China
Recruiting
A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary
NCT06279104
- Conditions
- Ovarian Clear Cell Carcinoma
- Locations
-
- Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
Not Yet Recruiting
Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer
NCT07718854
- Conditions
- Adenocarcinoma, Adenocarcinoma, Clear Cell, Adnexal Diseases, +20 more
- Locations
-
- Tufts Medical Center Boston, Massachusetts, United States
Not Yet Recruiting
Liposomal Irinotecan Combined With Sintilimab and Anlotinib in the Treatment of Recurrent or Persistent Ovarian Clear Cell Carcinoma
NCT07239622
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
Not specified
NCT04735861
- Conditions
- Ovarian Clear Cell Carcinoma
- Locations
-
- Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT03297424
- Conditions
- Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +36 more
- Locations
-
- Honor Health Scottsdale, Arizona, United States
- Sylvester Comprehensive Cancer Center / University of Miami Miller School of Medicine Miami, Florida, United States
- Columbia University Medical Center New York, United States
- South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States
NCT01914510
- Conditions
- Neoplasms, Ovarian Clear Cell Carcinoma
- Locations
-
- Tom Baker Cancer Centre Calgary, Alberta, Canada
- Cross Cancer Institute Edmonton, Alberta, Canada
- British Columbia Cancer Agency Vancouver, Alberta, Canada
- London Regional Cancer Program London, Ontario, Canada
Active, Not Recruiting
Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer
NCT05296512
- Conditions
- Gynecologic Cancer, Ovarian Clear Cell Carcinoma
- Locations
-
- University of Chicago Medicine Chicago, Illinois, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Comprehensive Cancer Center Rochester, Minnesota, United States
Active, Not Recruiting
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
NCT05226507
- Conditions
- ARID1A Gene Mutation, Adenocarcinoma, Adnexal Diseases, +24 more
- Locations
-
- Honor Health Phoenix, Arizona, United States
- UC San Diego Health - Moores Cancer Center La Jolla, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- Yale Gynecologic Oncology New Haven, Connecticut, United States